Stay informed with the latest litigation news. Explore now

Amicus Therapeutics competitive analysis

Latest publications and patents of Amicus Therapeutics New

Explore the latest publications and patents granted to Amicus Therapeutics, showcasing their recent innovations and technological advancements.

Last updated on: Sep 12, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Amicus Therapeutics

Nov 13, 2024Use Of Migalostat In Reducing The Risk Of Cerebrovascular Event In Patients With Fabry DiseaseGranted And Under Opposition
Oct 9, 2024Methods Of Treating Fabry Patients Having Renal ImpairmentGranted And Under Opposition
Jul 24, 2024Methods Of Treating Fabry Disease In Patients Having A Mutation In The Gla GeneGranted And Under Opposition
Nov 1, 2023Methods Of Treating Fabry Patients Having Renal ImpairmentGranted And Under Opposition
Oct 25, 2023Treatment Of Patients With Classic Fabry DiseaseGranted And Under Opposition
Sep 1, 2021Methods Of Treating Fabry Disease In Patients Having The G9331A Mutation In The Gla GeneGranted And Under Opposition
Apr 22, 2020Dosing Regimens For The Treatment Of Fabry DiseaseOpposition Rejected

Explore Amicus Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 18, 2025
Patent NumberGrant DateTitleTotal Oppositions
Nov 13, 2024Use Of Migalostat In Reducing The Risk Of Cerebrovascular Event In Patients With Fabry Disease3
Oct 9, 2024Methods Of Treating Fabry Patients Having Renal Impairment2
Jul 24, 2024Methods Of Treating Fabry Disease In Patients Having A Mutation In The Gla Gene2
Nov 1, 2023Methods Of Treating Fabry Patients Having Renal Impairment1
Oct 25, 2023Treatment Of Patients With Classic Fabry Disease1
Sep 1, 2021Methods Of Treating Fabry Disease In Patients Having The G9331A Mutation In The Gla Gene2
Apr 22, 2020Dosing Regimens For The Treatment Of Fabry Disease1

Latest PTAB cases involving Amicus Therapeutics New

Discover the latest PTAB cases involving Amicus Therapeutics, highlighting their recent legal challenges and patent disputes.

Top competitors of Amicus Therapeutics

Top competitors of Amicus Therapeutics based on patent oppositions.